Market Introduction
Degeneration of cartilage can lead to pain and chronic inflammation in joints of the human body. Furthermore, damaged cartilage can potentially influence the quality of a patient’s life. Continuous research and developments are innovating new techniques and methodologies to deal with damaged cartilages. A few of these techniques comprise joint replacement, cell therapies, and chondroplasty.
Market Overview and Dynamics
The Europe cartilage degeneration market is expected to reach US$ 3,365.09 million by 2027 from US$ 2,463.16 million in 2019; it is anticipated to grow at a CAGR of 4.1% from 2020 to 2027. The increasing prevalence of sports injuries and obesity is expected to boost the growth of the cartilage degeneration market in Europe. However, the market growth is impacted by the high cost of cartilage therapies and lack of reimbursement scenario.
Key Market Segments
In terms of procedure type, the joint replacement segment accounted for the largest share of the Europe cartilage degeneration market in 2019. In terms of application, the knee segment accounted for the largest share of the Europe cartilage degeneration market in 2019. Based on end user, the hospitals & specialty clinics segment accounted for the largest share of the Europe cartilage degeneration market in 2019.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the Asia Pacific cartilage degeneration market are the World Health Organization (WHO), British Journal of Sports Medicine, European Society of Sports Traumatology, Knee Surgery, Arthroscopy (ESSKA), Organization for Economic Cooperation and Development (OECD), and others.
Reasons to buy report
Europe Cartilage Degeneration Market Segmentation
By Procedure Type
By Application
By End User
By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 2,463.16 Million |
| Market Size by 2027 | US$ 3,365.09 Million |
| CAGR (2020 - 2027) | 4.1% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Procedure Type
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Cartilage Degeneration Market is valued at US$ 2,463.16 Million in 2019, it is projected to reach US$ 3,365.09 Million by 2027.
As per our report Europe Cartilage Degeneration Market, the market size is valued at US$ 2,463.16 Million in 2019, projecting it to reach US$ 3,365.09 Million by 2027. This translates to a CAGR of approximately 4.1% during the forecast period.
The Europe Cartilage Degeneration Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Cartilage Degeneration Market report:
The Europe Cartilage Degeneration Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Cartilage Degeneration Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Cartilage Degeneration Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Cartilage Degeneration Market
